GSK
740 hedge funds and large institutions have $7.84B invested in GSK in 2022 Q3 according to their latest regulatory filings, with 132 funds opening new positions, 243 increasing their positions, 272 reducing their positions, and 273 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
740
Holders Change
-158
Holders Change %
-17.59%
% of All Funds
12.8%
Holding in Top 10
13
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-23.53%
% of All Funds
0.22%
New
132
Increased
243
Reduced
272
Closed
273
Calls
$433M
Puts
$214M
Net Calls
+$219M
Net Calls Change
+$10.7M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$173M |
| 2 |
Two Sigma Advisers
New York
|
+$123M |
| 3 |
AC
Armistice Capital
New York
|
+$106M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$78.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77.7M |
